Harte Hanks vs Stran &
HHS and SWAG side by side, both in business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HHS and SWAG compare
Harte Hanks is the larger company, worth 1.4 times as much as Stran & ($29.9M against $22.0M).
Stran & grew revenue faster over the last twelve months (6.5% versus −7.3% for Harte Hanks).
Stran & keeps more of each dollar of sales as profit, with a net margin of 1.1% compared with −3.2% at Harte Hanks.
Stran & scores higher on the StockData Score (16 against 3 for Harte Hanks), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HHS | SWAG |
|---|---|---|
| Size and price | ||
| Market cap | $29.9M | $22.0M |
| Share price | $4.01 | $1.18 |
| Change, 1 year | 37.3% | −64.8% |
| Change, 5 years | −52.1% | −72.9% |
| Beta (5Y) | 0.71 | 0.83 |
| Employees | 1,719 | 154 |
| StockData Score | ||
| Total score | 3 | 16 (better) |
| Valuation score | 1 | 4 (better) |
| Growth score | 0 | 3 (better) |
| Performance score | 0 | 3 (better) |
| Health score | 2 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 16.9× |
| P/S | 0.2× | 0.2× (better) |
| P/B | 2.1× | 0.7× (better) |
| EV/EBITDA | – | 5.5× |
| P/FCF | – | 12.1× |
| FCF yield | −32.4% | 8.3% (better) |
| Fair value | – | $1.92 |
| Margin of safety | – | 38.6% |
| Growth | ||
| Revenue growth (TTM) | −7.3% | 6.5% (better) |
| Revenue growth, 5Y average | −2.0% | 25.2% (better) |
| Profitability | ||
| Gross margin | – | 31.1% |
| Operating margin | −4.6% | 0.45% (better) |
| Net margin | −3.2% | 1.1% (better) |
| FCF margin | −6.3% | 1.5% (better) |
| Return on equity | −29.0% | 4.3% (better) |
| Return on invested capital | −35.9% | 2.5% (better) |
| Financial health | ||
| Debt / equity | 0.45 (better) | 0.00 |
| Current ratio | 1.23 | 2.17 (better) |
| Altman Z-score | 14.66 (better) | 3.35 |
| Piotroski F-score | 4 | 5 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 29.1% | 12.8% |
| Held by insiders | 39.8% | 52.6% |
| Short interest, % of float | 0.98% | – |
Go deeper
- HHS stock overview
- HHS income statement
- HHS valuation and score
- SWAG stock overview
- SWAG income statement
- SWAG valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.